NextTrip Valuation
| NTRP Stock | USD 4.02 0.02 0.50% |
At this time, the firm appears to be overvalued. NextTrip secures a last-minute Real Value of $2.88 per share. The latest price of the firm is $4.02. Our model forecasts the value of NextTrip from analyzing the firm fundamentals such as Return On Equity of -3.69, shares outstanding of 1.65 M, and Operating Margin of (23.76) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that NextTrip's price fluctuation is dangerous at this time. Calculation of the real value of NextTrip is based on 3 months time horizon. Increasing NextTrip's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
NextTrip's intrinsic value may or may not be the same as its current market price of 4.02, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.02 | Real 2.88 | Hype 3.73 |
The intrinsic value of NextTrip's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NextTrip's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NextTrip helps investors to forecast how NextTrip stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NextTrip more accurately as focusing exclusively on NextTrip's fundamentals will not take into account other important factors: NextTrip Total Value Analysis
NextTrip is now projected to have valuation of 10.45 M with market capitalization of 6.64 M, debt of 828.28 K, and cash on hands of 27 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the NextTrip fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.45 M | 6.64 M | 828.28 K | 27 M |
NextTrip Investor Information
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 29.16. NextTrip last dividend was issued on the 28th of February 2020. The entity had 1:20 split on the 22nd of September 2023. Based on the analysis of NextTrip's profitability, liquidity, and operating efficiency, NextTrip is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in April.NextTrip Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. NextTrip has an asset utilization ratio of 9.01 percent. This connotes that the Company is making $0.0901 for each dollar of assets. An increasing asset utilization means that NextTrip is more efficient with each dollar of assets it utilizes for everyday operations.NextTrip Ownership Allocation
NextTrip holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.NextTrip Profitability Analysis
The company reported the previous year's revenue of 458.75 K. Net Loss for the year was (6.66 M) with profit before overhead, payroll, taxes, and interest of 23.87 K.About NextTrip Valuation
The stock valuation mechanism determines NextTrip's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of NextTrip based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of NextTrip. We calculate exposure to NextTrip's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NextTrip's related companies.Neurotrope, Inc., a biopharmaceutical company, focuses on the development of a product platform for the treatment of Alzheimers disease. The company was founded in 2012 and is based in New York, New York. Neurotrope operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
NextTrip Growth Indicators
Investing in growth stocks can be very risky. If the company such as NextTrip does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.1 M |
Additional Tools for NextTrip Stock Analysis
When running NextTrip's price analysis, check to measure NextTrip's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextTrip is operating at the current time. Most of NextTrip's value examination focuses on studying past and present price action to predict the probability of NextTrip's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextTrip's price. Additionally, you may evaluate how the addition of NextTrip to your portfolios can decrease your overall portfolio volatility.